The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

Nex-z is one of two late-stage projects on the go at Intellia, a specialist in CRISPR gene-editing co-founded by Nobel Prize ...

The severity of SARS-CoV-2 infections has waned since 2020, and uncertainty about the value of annual COVID shots has helped drive down adult vaccination rates. Among veterans who received a 2024-2025 ...

Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...

Partisan attacks on public health initiatives are undermining efforts to control COVID-19. Claims linking COVID-19 vaccines to pediatric deaths are disputed, citing data on hospitalizations and long ...

The codebreaking works like this. The GenomePAM method maps CRISPR's passwords directly in human cells. Instead of relying on artificial systems that are often limited (e.g., testing 1 to 3 sequences ...

A vaccine designed to prevent and potentially treat triple-negative breast cancer is showing promise in human trials and could be available by 2030. Cleveland Clinic researchers began exploring a ...

Libby Richards has received funding from the American Nurses Foundation, National Institutes of Health, and the Indiana Clinical and Translational Sciences Institute . As the autumn’s cool weather ...

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and difficult-to-treat cancers by harnessing dual-pathway nanoparticles that train the immune ...